Elite Pharmaceuticals (ELTP) Work In Process (2018 - 2026)
Elite Pharmaceuticals' Work In Process was $894,875 in fiscal Q2 2027 (quarter ended Sep 30, 2026), down 60.4% from $2.26 million a year earlier and down 58.1% from the prior quarter.
Elite Pharmaceuticals (ELTP) Work In Process (2018 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Work In Process at Elite Pharmaceuticals came in at $3.27 million, up 129.8% from FY2025.
- Work In Process shows a five-year compound annual growth rate of 33.1% (FY2021 to FY2026).
- In earlier fiscal years, Work In Process was $1.42 million in FY2025 (-21.2%), $1.8 million in FY2024 (+0.7%), $1.79 million in FY2023 (+48.9%) and $1.2 million in FY2022 (+54.0%).
- The fiscal Q2 2027 figure marks the lowest quarterly Work In Process since fiscal Q1 2024.
- Compared with a year earlier, Work In Process was higher in five of the last eight quarters, with growth averaging 27.6%.
- The best year-over-year quarter for Work In Process over five years was fiscal Q4 2026 (growth of 129.8%); the worst was fiscal Q3 2022 (a decline of 97.8%).
- Per Business Quant data, ELTP's Work In Process in the three fiscal quarters before Q2 2027 was $2.13 million (Q1 2027), $3.27 million (Q4 2026) and $3.65 million (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,291.18 Bn | 1,264.79 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 686.56 Bn | 606.42 Bn | 17.30 Bn |
| 3 | AbbVie | 525.29 Bn | 493.30 Bn | 13.12 Bn |
| 4 | Merck | 362.24 Bn | 325.18 Bn | 13.19 Bn |
| 5 | Novartis Ag | 313.66 Bn | 286.90 Bn | - |
| 6 | Astrazeneca | 286.68 Bn | 260.20 Bn | 13.26 Bn |
| 7 | Amgen | 253.44 Bn | 205.10 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 210.62 Bn | 185.73 Bn | 6.73 Bn |
| 9 | Pfizer | 165.41 Bn | 112.77 Bn | 12.56 Bn |
| 10 | Elite Pharmaceuticals | 397.46 Mn | 270.87 Mn | 15.99 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 894,875.00 |
| Jun 30, 2026 | 2.13 Mn |
| Mar 31, 2026 | 3.27 Mn |
| Dec 31, 2025 | 3.65 Mn |
| Sep 30, 2025 | 2.26 Mn |
| Jun 30, 2025 | 2.00 Mn |
| Mar 31, 2025 | 1.42 Mn |
| Dec 31, 2024 | 2.70 Mn |
| Sep 30, 2024 | 1.79 Mn |
| Jun 30, 2024 | 2.26 Mn |
| Mar 31, 2024 | 1.80 Mn |
| Dec 31, 2023 | 1.25 Mn |
| Sep 30, 2023 | 1.36 Mn |
| Jun 30, 2023 | 90,922.00 |
| Mar 31, 2023 | 1.79 Mn |
| Dec 31, 2022 | 99,283.00 |
| Sep 30, 2022 | 95,707.00 |
| Mar 31, 2022 | 1.20 Mn |
| Dec 31, 2021 | 966.00 |
| Sep 30, 2021 | 1,722.00 |
Elite Pharmaceuticals Work In Process API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=work-in-process&ticker=ELTP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "work-in-process", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=work-in-process&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();